Cannabinoid composition having an optimized fatty acid excipient profile

Abstract

A composition of matter for enhancing delivery of bioactive compounds, particularly cannabinoids into the human and animal organisms. The invention enhanced oral, transmucosal and transdermal delivery of a bioactive compound including cannabinoids through the use of an excipient having a desired ratio of fatty acids. The invention particularly includes a lipophilic phytocannabinoid such as THC or CBD, and an excipient fatty acid profile including palmitoleic acid and fatty acids selected from the group consisting of oleic acid and palmitic acid, and combinations thereof in optimal ratios. Macadamia nut oil is a preferred excipient having the desired lipid profile. Macadamia nut oil is a non-toxic plant oil, offers oxidation resistance to the fatty acids and cannabinoids to improve product shelf life, and has a sufficiently low melting temperature to remain liquid while refrigerated to further enhance product shelf life without changing the product phase from a liquid to a solid.

Description

FIELD OF THE INVENTION[0001]The present invention relates to the use and formulation of particular lipid profiles to optimize enteral, oral, transmucosal and transdermal delivery of bioactive compounds. More particularly, the invention relates to the optimization of excipient lipid profiles including particular fatty acids for delivery of cannabinoids.BACKGROUND OF THE INVENTION[0002]Formulations of bioactive compounds have been developed for human and animal consumption and therapeutic use since the beginning of recorded history. Since ancient times flowers and herbs were gathered and consumed therapeutically, often brewed into tea and cooked in food or compressed into a poultice and applied to the skin to treat wounds, pain and other maladies. Animals also self-medicate by eating plants.[0003]Transmucosal and transdermal methodologies often have an advantage over orally deliverable formulations because the human digestive tract can reduce the efficacy and bioavailability of any pa...

AI Technical Summary

Benefits of technology

The invention provides a composition that includes a cannabinoid, palmitic acid, oleic acid and a carrier oil. The ratio of palmitic acid and oleic acid to the cannabinoid is between 1:50 to 2000:1. This composition has been shown to increase the plasma concentration of the cannabinoid and improve its delivery through the sublingual and oral routes.

Problems solved by technology

Additionally stomach acids can inhibit the effectiveness of oral delivery.

This is a tortuous path, so there are challenges to optimizing the speed of delivery and efficacy of bioactive compounds.

This is a more direct pathway yet there are still challenges to optimizing delivery and efficacy of bioactive compounds.

There exists the challenge to penetrate the mucus membranes.

Images